PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma ; volume:16 ; number:1 ; day:28 ; month:7 ; year:2016 ; pages:1-12 ; date:12.2016
BMC cancer ; 16, Heft 1 (28.7.2016), 1-12, 12.2016
- Creator
-
Ross, R. L.
- Contributor
-
McPherson, H. R.
Kettlewell, L.
Shnyder, S. D.
Hurst, C. D.
Alder, O.
Knowles, M. A.
SpringerLink (Online service)
- DOI
-
10.1186/s12885-016-2570-0
- URN
-
urn:nbn:de:1111-2016072950156
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ross, R. L.
- McPherson, H. R.
- Kettlewell, L.
- Shnyder, S. D.
- Hurst, C. D.
- Alder, O.
- Knowles, M. A.
- SpringerLink (Online service)
Other Objects (12)
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited
Carcinogenesis of PIK3CA
PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer
PIK3CA-mutations in breast cancer
PIK3CA-Amplifikationen in humanen Lungenkarzinomen
XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis
MiR-142-5p Suppresses Tumorigenesis by Targeting PIK3CA in Non-Small Cell Lung Cancer
Prävalenz von PIK3CA-Genmutationen beim Mammakarzinom
Comparison between urothelial and non-urothelial urethral cancer
Targeting DNA damage repair genes in cisplatin and gemcitabine resistant urothelial carcinoma cells
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
PIK3CA alterations in Middle Eastern ovarian cancers
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited
Carcinogenesis of PIK3CA
PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer
PIK3CA-mutations in breast cancer
PIK3CA-Amplifikationen in humanen Lungenkarzinomen
XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis
MiR-142-5p Suppresses Tumorigenesis by Targeting PIK3CA in Non-Small Cell Lung Cancer
Prävalenz von PIK3CA-Genmutationen beim Mammakarzinom
Comparison between urothelial and non-urothelial urethral cancer
Targeting DNA damage repair genes in cisplatin and gemcitabine resistant urothelial carcinoma cells
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
PIK3CA alterations in Middle Eastern ovarian cancers
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited
Carcinogenesis of PIK3CA
PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer
PIK3CA-mutations in breast cancer
PIK3CA-Amplifikationen in humanen Lungenkarzinomen
XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis
MiR-142-5p Suppresses Tumorigenesis by Targeting PIK3CA in Non-Small Cell Lung Cancer
Prävalenz von PIK3CA-Genmutationen beim Mammakarzinom
Comparison between urothelial and non-urothelial urethral cancer
Targeting DNA damage repair genes in cisplatin and gemcitabine resistant urothelial carcinoma cells
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers